Onconetix Inc (ONCO) is a Healthcare · Biotechnology company listed on NASDAQ. Price $0.66 (-0.54%), Market cap $0.00B, 52-week low–high $0.07 ~ $4.92.
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnat
Financial statements, price targets, institutional (13F) holdings and related news for Onconetix Inc are updated in real time on BlackAll Trade.
Onconetix Inc trades at $0.66 (-0.54%). Real-time quotes and charts are available on BlackAll Trade.
Onconetix Inc has a market cap of about $0.00B.
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-Europ